Next Generation Sequencing Market 2019 Top Leading Players: Roche Holding Ag, Agilent Technologies, BGI, Biomatters, Qiagen, Dnastar, Genomatix Software Gmbh, Macrogen, Oxford Nanopore Technologies, Pacific Biosciences

Next-generation sequencing (NGS) refers to DNA sequencing technologies such as Illumina (Solexa) sequencing, Roche 454 sequencing, Ion torrent: Proton / PGM sequencing, SOLiD sequencing that allows to sequence DNA and RNA much more quickly and cheaply than the previously used Sanger sequencing which has revolutionized genomic research.

The Next Generation Sequencing market is driven by several factors such as increasing demand for NGS technology in drug discovery, growth in genome mapping programs and technological advancements in genetic sequencing are driving the NGS market globally. But the Next Generation Sequencing market is affected by standardization concerns over NGS based diagnostics and lack of skilled professionals in this field.

Download Sample Copy of Next Generation Sequencing Market @ https://www.orbisresearch.com/contacts/request-sample/2588624

Top Players:
• Roche Holding Ag
• Agilent Technologies Inc
• BGI (Beijing Genomics Institute)
• Biomatters Ltd
• Qiagen
• Dnastar Inc
• Gatc Biotech Ag
• Genomatix Software Gmbh
• Illumina Inc
• Knome Inc
• Thermo Fisher Scientific
• Macrogen Inc
• Oxford Nanopore Technologies Ltd
• Pacific Biosciences
• Partek Incorporated
• Perkin Elmer

Technology Insights:
The global Next-generation Sequencing market is segmented by technology into whole genome sequencing, targeted re-sequencing, whole exome sequencing, RNA sequencing, Chip sequencing, De Novo sequencing, and methyl sequencing. Targeted sequencing occupies the largest share due to the presence of several benefits associated with a smaller dataset and reduction in sequencing costs. In addition, Increasing count of protein expression analysis projects are expected to rise due to the presence of large sets of DNA-based sequence data. Whole genome sequencing (WGS) which includes genome, microbial and de novo genome applications is expected to grow rapidly due to increasing number of research programs aimed at mapping human and non-human whole genomes combined with reducing costs of WGS.

Check Discount @ https://www.orbisresearch.com/contacts/discount/2588624

Product Insights:
By product type, the global next-generation sequencing market is segmented into Instruments, and Reagents & Consumables. The Consumables segment holds the largest share in the global next generation sequencing market.

By applications, the Next Generation Sequencing market is segmented into drug discovery, personalized medicine, genetic screening, diagnostics, infectious diseases, agricultural and animal research, and others. Based on end-user, the market is segmented into Services, Hospitals and Healthcare Institutions, Academics, Biotechnology and Pharmaceutical Firms. Among these

Regional Insights:
Geographically, the Next Generation Sequencing market is segmented into North America, South America, Europe, Asia Pacific and RoW. North America accounted for largest share due to the presence of advanced technological healthcare framework, growing adoption of reduction in the cost of sequencing per base pair, and high R&D investment for genomic sequence determination for biomarkers research.

Enquiry before Buying @ https://www.orbisresearch.com/contacts/enquiry-before-buying/2588624

About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Us:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas - 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9120641 01019
Email id: sales@orbisresearch.com

This release was published on openPR.